Trial Outcomes & Findings for BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation (NCT NCT03670264)

NCT ID: NCT03670264

Last Updated: 2021-07-13

Results Overview

Adolescent completion of the tobacco cessation program, defined as the proportion of tobacco users identified in the clinic that enroll, use, and complete the Quitline program compared across the 3 groups

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

15 participants

Primary outcome timeframe

10 weeks

Results posted on

2021-07-13

Participant Flow

Participant milestones

Participant milestones
Measure
Quitline Incentive
The incentive structure emphasizes engaging with the Quitline Delivered Treatment, with an additional smaller payment for tobacco cessation. Each adolescent can receive compensation for enrolling in the Quitline, for maintaining involvement in the Quitline program (per call for up to 5 calls), and, for those reporting abstinence, for submitting the cotinine swab and for confirmed quitting (negative salivary cotinine). Study procedures, payments and reminders are managed through the Way to Health (WTH) platform.
Tobacco Cessation Incentive
The incentive structure emphasizes quitting regardless of engagement with the Quitline Delivered Treatment (though the Quitline will be presented as a helpful tool). Each adolescent will receive compensation for enrolling in the Quitline and, for those reporting abstinence, compensation for submitting the cotinine swab and for confirmed quitting (negative salivary cotinine). Study procedures, payments and reminders are managed through the WTH platform.
No Financial Incentive
No financial incentive to engage in Quitline Delivered Treatment or report abstinence. Study procedures and reminders are managed through the WTH platform. Way to Health (WTH) Platform: The WTH platform is a web-based platform that sends reminder text messages to participants regarding study procedures and has has secure financial tracking and processing systems to manage participant payments, including the ability to track earnings and pay participants via a non-integrated payment system. Quitline Delivered Treatment: The quitline provides tobacco cessation treatment to individuals who enroll in treatment. This treatment includes 5 proactive counseling calls, each designed to help develop problem-solving and coping skills, secure social support, and plan for long-term abstinence. Participants can also call an 800 telephone number as needed for additional support between proactive calls.
Overall Study
STARTED
5
5
5
Overall Study
COMPLETED
5
5
5
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Quitline Incentive
n=5 Participants
The incentive structure emphasizes engaging with the Quitline Delivered Treatment, with an additional smaller payment for tobacco cessation. Each adolescent can receive compensation for enrolling in the Quitline, for maintaining involvement in the Quitline program (per call for up to 5 calls), and, for those reporting abstinence, for submitting the cotinine swab and for confirmed quitting (negative salivary cotinine). Study procedures, payments and reminders are managed through the Way to Health (WTH) platform.
Tobacco Cessation Incentive
n=5 Participants
The incentive structure emphasizes quitting regardless of engagement with the Quitline Delivered Treatment (though the Quitline will be presented as a helpful tool). Each adolescent will receive compensation for enrolling in the Quitline and, for those reporting abstinence, compensation for submitting the cotinine swab and for confirmed quitting (negative salivary cotinine). Study procedures, payments and reminders are managed through the WTH platform.
No Financial Incentive
n=5 Participants
No financial incentive to engage in Quitline Delivered Treatment or report abstinence. Study procedures and reminders are managed through the WTH platform. Way to Health (WTH) Platform: The WTH platform is a web-based platform that sends reminder text messages to participants regarding study procedures and has has secure financial tracking and processing systems to manage participant payments, including the ability to track earnings and pay participants via a non-integrated payment system. Quitline Delivered Treatment: The quitline provides tobacco cessation treatment to individuals who enroll in treatment. This treatment includes 5 proactive counseling calls, each designed to help develop problem-solving and coping skills, secure social support, and plan for long-term abstinence. Participants can also call an 800 telephone number as needed for additional support between proactive calls.
Total
n=15 Participants
Total of all reporting groups
Age, Continuous
18.2 Years
STANDARD_DEVIATION 1.6 • n=5 Participants
16.6 Years
STANDARD_DEVIATION 1.1 • n=7 Participants
17.6 Years
STANDARD_DEVIATION 2.1 • n=5 Participants
17.4 Years
STANDARD_DEVIATION 1.7 • n=4 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
8 Participants
n=4 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
2 Participants
n=7 Participants
1 Participants
n=5 Participants
7 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
White
5 Participants
n=5 Participants
5 Participants
n=7 Participants
4 Participants
n=5 Participants
14 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Region of Enrollment
United States
5 participants
n=5 Participants
5 participants
n=7 Participants
5 participants
n=5 Participants
15 participants
n=4 Participants
Number of participants enrolled in the Quitline
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
6 Participants
n=4 Participants

PRIMARY outcome

Timeframe: 10 weeks

Population: The number of participants who enrolled in the Quitline

Adolescent completion of the tobacco cessation program, defined as the proportion of tobacco users identified in the clinic that enroll, use, and complete the Quitline program compared across the 3 groups

Outcome measures

Outcome measures
Measure
Quitline Incentive
n=5 Participants
The incentive structure emphasizes engaging with the Quitline Delivered Treatment, with an additional smaller payment for tobacco cessation. Each adolescent can receive compensation for enrolling in the Quitline, for maintaining involvement in the Quitline program (per call for up to 5 calls), and, for those reporting abstinence, for submitting the cotinine swab and for confirmed quitting (negative salivary cotinine). Study procedures, payments and reminders are managed through the Way to Health (WTH) platform.
Tobacco Cessation Incentive
n=5 Participants
The incentive structure emphasizes quitting regardless of engagement with the Quitline Delivered Treatment (though the Quitline will be presented as a helpful tool). Each adolescent will receive compensation for enrolling in the Quitline and, for those reporting abstinence, compensation for submitting the cotinine swab and for confirmed quitting (negative salivary cotinine). Study procedures, payments and reminders are managed through the WTH platform.
No Financial Incentive
n=5 Participants
No financial incentive to engage in Quitline Delivered Treatment or report abstinence. Study procedures and reminders are managed through the WTH platform.
Program Completion
1 Participants
2 Participants
3 Participants

SECONDARY outcome

Timeframe: 10 weeks

Confirmation of abstinence will be measured by assessing if participants salivary cotinine concentration are \<30 ng per milliliter

Outcome measures

Outcome data not reported

Adverse Events

Quitline Incentive

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Tobacco Cessation Incentive

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No Financial Incentive

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Brian Jenssen

Children's Hospital of Philadelphia

Phone: 215-554-4390

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place